NCT03911726View on ClinicalTrials.gov

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

NAActive, not recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Schizophrenia

Interventions

RADIATION

Single PET/MR-measurement

A single PET/MR-measurement using \[18F\]Fallypride with a duration of 180min. Within this measurement, the dopamine receptor agonist apomorphine is applicated.

Trial Locations (1)

68159

Central Institute of Mental Health, Mannheim

All Listed Sponsors

lead

Central Institute of Mental Health, Mannheim

OTHER